/Investor DB

Windham Capital Partners

Venture capitalActively deploying

New York · Series A–Growth · 17 people tracked

Also known as WINDHAM CAPITAL PARTNERS LLC · Windham Venture Partners

Find your way into Windham Capital Partners

Sign up to see every warm intro you have to Windham Capital Partners

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Windham Capital Partners team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Windham Capital Partners invests in the healthcare sector, drawing on more than two decades of experience and deep industry expertise. The firm supports healthcare entrepreneurs and companies, backing areas such as medical devices, digital health, and life-science technologies. It stresses the importance of building trusted, long-term relationships with entrepreneurs and CEOs, viewing those relationships as being as valuable as the capital invested. The team combines investment professionals with operating partners, clinicians, scientists, and policy experts who help source opportunities, evaluate emerging technologies, and support portfolio companies after investment.

Source: firm website, verified Sep 27, 2026.

Stage
Series A–Growth
Check
$1M – $5M
HQ
New York, New York, US
Leads rounds
Leads
Instruments
Equity
Founded
2006
Private fund assets
$94.1M
VC funds
6
Tracked investments
46
IPOs
4
Acquisitions
3

Team · 17 people

from the firm's website & public directories

Founder mafia

2 people who came through Windham Capital Partners went on to found or lead other companies.

What they invest in

from 38 of 46 portfolio companies

Healthtech ×31Medical Devices ×16Biotech ×15Digital Health ×12Consumer ×5Hardware ×5AI & Machine Learning ×4SaaS ×4

HQs:United States×35

Who they back

founder profiles across 21 portfolio companies
43%
solo founders
9 of 21 mapped founding teams
41%
repeat founders
of 22 founders with career history

Founding team size:solo founder×92 founders×73 founders×34+ founders×2

Where their founders studiedfrom 21 founders with education data

Stanford University ×5Massachusetts Institute of Technology ×3Columbia University Vagelos College of Physicians and Surgeons ×2Duke University ×2Tel Aviv University ×2

What their founders studiedfrom 22 founders with field-of-study data

Life Sciences ×7Engineering ×6Medicine ×6Economics ×4Physics ×3Business & Management ×2Computer Science ×2

Where their founders worked beforefrom 22 founders with career history

Moximed ×3EXPLORAMED DEVELOPMENT LLC ×2NeoTract ×2

8 founders hold a PhD · 4 hold an MBA (of 22 with degree data)

Investments · 46 tracked

founders shown can be your intro path

By year:2025 · 12021 · 22020 · 22019 · 12018 · 22016 · 12015 · 32014 · 12008 · 114 dated

Alconalcon.cominNYSE: ALC

Alcon is a global eye care company that develops and manufactures ophthalmologic products and surgical systems to improve vision.

HardwareHealthtechImpact & Social GoodMedical DevicesFort Worth, US

David Endicott(CEO)in

Alto Neurosciencealtoneuroscience.comin𝕏NYSE: ANRO

Alto Neuroscience is a clinical-stage biopharmaceutical company developing biology-driven medicines for neuropsychiatric conditions, using measurements of brain biology to predict clinical response and identify patients likely to benefit from its drug candidates.

BiotechDigital HealthMental HealthMountain View, US

Amit Etkin(Founder)inAdam Savitz(Executive Officer)inMichael Hanley(Executive Officer)Nicholas Smith(Chief Financial Officer and Chief Business Officer)inAaron Weaver(Director)Po Yu (Jeff) Chen(Director)

Co-investorsAble PartnersAlpha Wave GlobalGaingelsInVivium CapitalK2 HealthVenturesKorify Capital+12 more

CVRxcvrx.comin𝕏NASDAQ: CVRXJul 2020

CVRx develops Barostim, an implantable medical device that uses baroreceptor activation to treat heart failure patients and improve their functional capacity and quality of life.

BiotechHealthtechMedical DevicesAustin, US

Craig Palmer(Executive Officer)inNadim Yared(Executive Officer, Director)inDean Bruhn-Ding(Executive Officer)inJohn Brintnall(Executive Officer)inLiz Galle(Executive Officer)Kevin Hykes(President, Chief Executive Officer & Director)in

Co-investorsABS VenturesNew Enterprise Associates (NEA)Treo Ventures, LlcYsios CapitalAction Potential Venture Capital Ltd.Hatteras Venture Partners+1 more

NovoCurenovocure.comin𝕏NASDAQ: NVCR

Novocure develops Tumor Treating Fields therapy for treating aggressive forms of cancer.

BiotechHealthtechMedical Devices

Yoram PaltiinWilliam F. Doyle(Executive Chairman)Frank Leonard(Chief Executive Officer)in

Co-investorsPfizer Venture Investments

androsandros.coin𝕏

Andros provides data-driven provider network management solutions for healthcare organizations, offering strategic and execution support across the full network lifecycle.

Enterprise SoftwareHealthtechSaaSNew York City, US

Andrew Camel(Founder)inMike Simmons(Founder)in

Co-investorsBowery CapitalChicago VenturesMarram VenturesMeridian Street CapitalQuesta CapitalPrimary Venture Partners

Blueprinthealthblueprinthealth.org

Blueprint Health is a healthcare-focused accelerator that runs a three-month program helping startups gain customers, raise capital, and refine their investor pitch.

Digital HealthHealthtech

Cartivacartiva.net

HealthtechAlpharetta, US

Carribeth Ramey(Executive Officer)Peter J. Pizzo(Executive Officer)Robert R. Singer(Executive Officer)Deborah Moore(Executive Officer)Timothy Patrick(Executive Officer, Director)Peter J. Pizzo, III(Executive Officer)

ChromaCodechromacode.comin𝕏

ChromaCode develops a High-Definition PCR (HDPCR) multiplexing platform that enables genomic solutions for oncology and precision medicine, offering faster results and cost-effective workflows through automated interpretation and cloud-based software.

AI & Machine LearningBiotechHealthtechMedical DevicesCarlsbad, US

Paul Flook(Executive Officer, Director)inGregory J. Gosch(Executive Officer, Director)Lynne Rollins(Executive Officer)Aditya Rajagopal(Director)inAxel Scherer(Director)

BoardJustin Klein(Director)in

Co-investorsAdjuvant CapitalGlobal BrainMoore Venture PartnersNew Enterprise Associates (NEA)Domain AssociatesDomain Partners+2 more

Clever Care Health Planclevercarehealthplan.comin

Clever Care is a culturally and linguistically sensitive Medicare Advantage health plan serving Southern California that integrates Eastern and Western medicine approaches.

HealthtechInsurTechSouthern California, US

Myong Sun Lee(Executive Officer, Director)Hiep Dinh Pham(Executive Officer, Director)Dave Firdaus(Executive Officer, Director)

Co-investorsGV (Google Ventures)Norwest Venture PartnersGlobal Founders CapitalNovo HoldingsAV8 VenturesFigure 8 Investments+1 more

ControlRadcontrolrad.com

HealthtechRadnor, US

Guillaume Bailliard(Executive Officer, Director)

BoardSteven Nichtberger(Director)Amir Yaron(Director)Harlan Weisman(Director)Allon Guez(Director)Haim Melman(Director)

Co-investorsQuesta Capital

Coravincoravin.comin𝕏

Coravin makes a wine-preservation system that uses a thin needle and Argon gas to pour wine without removing the cork, keeping the remaining wine fresh for weeks to years.

ConsumerDirect to ConsumerHardwareBurlington, US

Greg Lambrecht(Founder)inGreg Lembrecht(Director)Frederic Levy(Executive Officer, Director)inNicholas Lazaris(Executive Officer, Director)Calli Prendergast(Executive Officer)inDave Krupinskiin

Co-investorsAlpine MeridianBattery VenturesNew Enterprise Associates (NEA)

Cureatrcureatr.com

New York, US

Joseph Mayer(Director)inJames Bradley(Director)Bharath Ganesan(Director)Richard Resnick(Executive Officer, Director)

BoardJohn Clarke(Director)inTodd Pietri(Director)in

Co-investorsCardinal PartnersActivate Venture Partners

Delfi Diagnosticsdelfidiagnostics.comin

DELFI Diagnostics develops FirstLook Lung, a blood-based laboratory test for lung cancer screening that identifies genome-wide alterations in individuals eligible for screening.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesBaltimore, US

Victor Velculescu(Founder)inPeter Bach(Executive Officer)Jennifer Buechel(Executive Officer)Douglas Schenkel(Executive Officer)Nicholas Dracopoli(Executive Officer)inSusan Tousi(Chief Executive Officer)in

Co-investorsAV8 VenturesForesite CapitalIllumina VenturesInitiate Venture PartnersMenlo VenturesMerck Global Health Innovation Fund+7 more

Earlensearlens.com

Earlens makes a hearing aid that vibrates the eardrum directly rather than using speakers to amplify sound, allowing amplification across a broad audible frequency range including higher frequencies for speech understanding.

HardwareHealthtechMedical DevicesMenlo Park, US

Rodney Perkins, M.D.(Director)William M. Facteau(Executive Officer, Director)Bernard Shay(Executive Officer)Phil Lyons(Executive Officer)Brent Edwards(Executive Officer)Greg Koskowich(Executive Officer)

Co-investorsAisling CapitalNew Enterprise Associates (NEA)Lightstone VenturesMorgenthalerSightLine Partners

Finexiofinexio.comin𝕏Series B · Oct 2020 · $23M

Finexio helps companies automate accounts payable and payment processes, replacing paper-based and manual workflows with digital payment solutions.

Enterprise SoftwareFintechSaaSOrlando, US

Ernest Rolfson(Founder and CEO)inChris Wyattin

Co-investorsAdvection Growth CapitalFlorida FundersLoeb.nycPatriot Financial PartnersAlpine MeridianInovia Capital+2 more

Fore Biotherapeuticsfore.bioin𝕏

Fore Biotherapeutics is a clinical-stage oncology company developing targeted cancer therapies, including its lead plixorafenib program.

BiotechHealthtechMedical DevicesPhiladelphia, US

Co-investorsHBM Healthcare InvestmentsHBM PartnersLG Technology VenturesNovartis Venture FundOrbiMedPontifax Venture Capital+4 more

GlySensglysens.comDec 2015

HealthtechSan Diego, US

JOSEPH Y. LUCISANO(CHIEF TECHNOLOGY OFFICER)WILLIAM H. MARKLE(PRESIDENT AND CEO)in

BoardADAM E. FINE(Director)inSAMUEL V. GOEKJIAN(Director)ROBERT L. ENGLER(Director)ORVILLE G. KOLTERMAN(Director)

Invuityinvuity.com

Sophisticated optics for illumination and enhanced visualization in surgical procedures.

HealthtechSan Francisco, US

Kenneth Trauner(Executive Officer, Director)Alex Vayser(Executive Officer)Philip Sawyer(Executive Officer, Director)inTheresa Brandner-Allen(Executive Officer)Brett Robertson(Executive Officer)Doug Rimer(Executive Officer)

Co-investorsAlpine MeridianAvedro, Inc.HEALTHCARE ROYALTY PARTNERSKleiner PerkinsValence Advantage Life SciencesWellington Management

Kinemakinema.com𝕏Seed · May 2021 · $2M

Kinema is a streaming platform offering documentaries and films across genres such as drama, comedy, and music, with content presented by various film distributors.

ConsumerMedia & Entertainment

Christie Marchese(Founder)inRish Aggarwal(Founder)in

Co-investorsHelmKindred VenturesAndreessen HorowitzGalaxy InteractiveHuman VenturesI2BF Global Ventures+5 more

Locemialocemia.com

Locemia develops a simplified delivery device for glucagon that helps rescue people experiencing severe hypoglycemia caused by diabetes.

BiotechDigital HealthHealthtechMedical Devices

Dr. Claude Piché(Co-Creator and CEO)Robert Oringer(Co-Creator and Chairman)Martin Lafontaine(Chief Commercial Officer)Robert Coburn(Chief Financial Officer)

MC10mc10inc.comin𝕏acquired by Medidata

MC10 developed conformal BioStamp wearable sensors and clinical analytics for physiological data capture in clinical research.

BiotechDigital HealthHealthtechMedical DevicesLexington, US

John Rogers(Director)David Icke(Executive Officer, Director)Alice Sansone(Executive Officer)Steven N. Tannenbaum(Executive Officer)Scott D. Pomerantz(Executive Officer, Director)

BoardMarc Singer(Director)in

Co-investorsBraemar Energy VenturesMitsui Global InvestmentOUP (Osage University Partners)Aberdare VenturesNorth Bridge Venture Partners & Growth Equity

Nebulanebula.myAug 2018 · $4.3M

Nebula is a cloud gaming platform that lets users play PC games from any device, offering access to a library of games and high-performance gaming computers for a single subscription price.

Cloud ComputingConsumerGamingMountain View, US

Gordon Stitt(Executive Officer, Director)Devin Carlen(Director)Chris C. Kemp(Executive Officer, Director)

BoardLouis Toth(Director)inMark Leslie(Director)Peter Bell(Director)

Co-investorsAlpha Startups Pre-AcceleratorARCH Venture PartnersComcast VenturesF-Prime CapitalFenbushi CapitalHemi Ventures, Llc+5 more

Nebula Genomicsnebula.orgAug 2018 · $4.3M

Nebula Genomics offers whole genome sequencing, providing consumers with health, trait, ancestry, and oral microbiome reports based on 100% of their DNA.

BiotechConsumerDigital Health

George Church(Founder)in

Co-investorsF-Prime CapitalHemi Ventures, LlcHikma VenturesARCH Venture PartnersFenbushi CapitalKhosla Ventures+2 more

NeoTractneotract.comDec 2016

HealthtechPleasanton, US

Ted Lamson(Founder)inDavid Amerson(Executive Officer, Director)William Facteau(Director)Joshua Makower(Director)Theodore Lamson(Founder)

BoardRyan Drant(Director)

Co-investorsNew Enterprise Associates (NEA)Johnson & Johnson Innovation – JJDC

Neuspera Medical, Inc.neuspera.comin𝕏

Neuspera Medical develops an integrated sacral neuromodulation (iSNM) system that implants a smart neurostimulator near the sacral nerve to treat urinary urge incontinence, a symptom of overactive bladder.

BiotechHealthtechMedical DevicesSan Jose, US

Alexander Yeh(Founder)inMilton M. Morris(Executive Officer, Director)inDave Van Meter(Chief Executive Officer)Steve Paul(Chief Commercial Officer)in

Co-investorsAlumni VenturesCerity Partners VenturesForeground CapitalPortfoliaTreo Ventures, LlcAction Potential Venture Capital Ltd.+2 more

Nuelleaytubio.comin𝕏Apr 2015

A specialty pharmaceutical company focused on developing and commercializing novel therapeutics for central nervous system conditions, serving patients and healthcare providers.

BiotechHealthtechMedical DevicesMountain View, US

Joshua Makower(Executive Officer, Director)Stefano Curti(Executive Officer, Director)

BoardDavis Yang(Director)John Nehra(Director)Yi Li(Director)Ryan Drant(Director)

Co-investorsRuvento Ventures Pte Ltd.

Nuvairanuvaira.comin𝕏Feb 2019 · $79M

Nuvaira develops the dNerva Lung Denervation System, a catheter-based device used in a one-time, outpatient bronchoscopic procedure that disrupts pulmonary nerve input to treat chronic obstructive pulmonary disease (COPD).

HardwareHealthtechMedical DevicesMinneapolis, US

Martin Mayse(Founder)inSteve Dimmer(Founder)inDennis Wahr(President & CEO)inLisa Flaherty(Chief Strategy Officer)inSteve Sathre(Vice President of Finance)inSteve Paidosh(Vice President of Operations)

Co-investorsEndeavour VisionLightstone VenturesMorgenthalerQiming Venture PartnersRichard King Mellon FoundationSplit Rock Partners+2 more

PainTEQpainteq.cominAug 2025

PainTEQ develops medical devices and implants for sacroiliac joint dysfunction, offering solutions ranging from biologicalbone allografts to titanium implants as alternatives to injections or fusion surgery.

Deep TechHealthtechMedical DevicesTampa, US

Shanth(Chief Executive Officer)

Co-investorsSignet Healthcare Partners

Personal Genome Diagnosticspersonalgenome.comin𝕏

A precision oncology company providing genomic testing and resources to support cancer care decisions, operating under Labcorp Oncology.

BiotechDigital HealthHealthtechMedical DevicesBaltimore, US

Victor Velculescu(Executive Officer, Director, Promoter)inLuis A. Diaz, Jr.(Executive Officer, Director, Promoter)Sam Angiuoli(Executive Officer)inSian Jones(Executive Officer)inLisa Kann(Executive Officer)inAnthony Newton(Executive Officer)

Co-investors3B Future Health FundCatalio Capital Management, LPCo-Win VenturesNew Enterprise Associates (NEA)Vensana Capital

Revelle Aestheticsrevelleaesthetics.comin

Revelle Aesthetics develops and commercializes the Avéli device, a precision medical technology for cellulite reduction.

FemTechHealthtechMedical DevicesMountain View, US

Eb Bright(Co-Founder and Chief Administrative Officer)inJonathan Podmore(Co-Founder and Chief Technology Officer)inJoshua Makower(Director)Earl A. Bright II(Director)Caroline Van Hove(Executive Officer, Director)in

BoardPhilippe Schaison(Director)in

Co-investorsNew Enterprise Associates (NEA)Runway Growth CapitalClarus Ventures

RxWarerxware.io

RxWare is a "Service as a Software" company that uses its AI-powered intelligence engine, RxWare OS, to move patients from prescription to first fill by providing real-time visibility and coordinated intervention across the patient access journey.

AI & Machine LearningDigital HealthHealthtechWilmington, US

Raeanna Lewarne(Executive Officer, Director)Shlomi Aflalo(Executive Officer, Director)Ori Karev(Director)Yishai Knobel(Executive Officer, Director)

BoardAdam Fine(Director)inGregg Dearhammer(Director)

Co-investorsVodia VenturesZORAStartUp Health

Science Exchangescienceexchange.comin𝕏SeedAcquired

Science Exchange provides operational infrastructure for life sciences R&D, connecting organizations, suppliers, and workflows to streamline contracting, compliance, onboarding, and financial coordination across the research ecosystem.

BiotechEnterprise SoftwareHealthtechSaaSSan Francisco, US

Elizabeth Iorns(President \u0026 CEO; Chairman of the Board)inDan Knox(COO)inMark Layden(CEO & Chairman)inRyan Abbott(Founder)Nichola Mente(Executive Assistant To Chief Executive Officer)Omid Karkouti(Vice President of Sales)

Co-investorsCollaborative FundIndex VenturesLerer HippeauNorwest Venture PartnersSpider CapitalUnion Square Ventures (USV)+6 more

SubjectWellsubjectwell.comin

SubjectWell operates a patient network that links individuals to clinical trials and connects them with healthcare providers and pharmaceutical sponsors.

BiotechDigital HealthHealthtech

Co-investorsAsset Management CompanyATPGeekdomHealthy VenturesMartin VenturesAsset Management Ventures

Tailormedtailormed.coin

TailorMed provides a platform that helps patients access, afford, and stay on their prescribed medications by connecting them to financial assistance and support programs.

Digital HealthHealthtechSaaS

Adam Siton(Founder)inIsrael (Srulik) Dvorsky(Founder)in

Co-investorsAccelmed PartnersAllumia VenturesBallad VenturesBridges IsraelOSF VenturesSamsung Next+3 more

Transactistransactis.comJan 2008 · $4MAcquired

Transactis provides electronic bill presentment and payment software for banks, billers and their business customers.

New York, US

ALEX REZNIK(Executive Officer)ANNAMARIE MALARA(Executive Officer)JAMES FORNARI(Executive Officer, Director)SCOTT DICKEY(Executive Officer)JOHN DICKEY(Executive Officer)

BoardJOE PROTO(Executive Officer, Director)

Co-investorsAlpine MeridianFf Venture CapitalRunway Venture PartnersMetamorphic VenturesStarVest Partners

Upward Healthupwardhealth.com

Home-based primary and behavioral care provider based in Long Island, NY

Co-investorsCorewell Health VenturesHeritage GroupNoro-Moseley Partners

Valera Healthvalerahealth.comin𝕏Nov 2021 · $15M

Valera Health provides virtual mental health care for adults and children, connecting patients with vetted in-house providers who develop personalized, data-driven treatment plans.

Digital HealthHealthtechMental HealthBrooklyn, US

Dr. Thomas Tsang(Executive Officer, Director)inCraig Albright(Executive Officer, Director)inArick Rynearson(Director)Ofer Sharon(Director)

BoardAdam Fine(Director)inJames Nahirny(Director)

Co-investorsConnecticut InnovationsCorewell Health VenturesCU Healthcare Innovation FundFigure 8 InvestmentsGaingelsGreyMatter+3 more

Vergent Biosciencevergentbio.com

Vergent develops tumor-targeted fluorescent imaging agents designed to enhance surgeons' ability to visualize tumors during minimally invasive and robotic-assisted cancer surgery.

BiotechDeep TechHealthtechMedical DevicesMinneapolis, US

Jeffrey Yurecko(Executive Officer)John Santini(Executive Officer, Director)John Santini, PhD(President and Chief Executive Officer)

BoardJeff Julkowski(Director)Raymond Wong(Director)Anita Watkins(Director)in

Co-investorsColle Capital PartnersSpring Mountain Capital

VytronUSvytronus.comOct 2014 · $31.6M

HealthtechSunnyvale, US

John Pavlidis(Executive Officer, Director)Michael Horzewski(Executive Officer, Director)Michael Pederson(Executive Officer, Director)

BoardDavid McIntyre(Director)Justin Klein(Director)Sami Hamade(Director)

Co-investorsNew Enterprise Associates (NEA)BioStar Ventures

WellDocwelldoc.comin𝕏Jul 2015

Welldoc develops an AI-driven digital health platform focused on cardiometabolic disease management, providing personalized treatment solutions for patients with diabetes and related conditions.

AI & Machine LearningDigital HealthHealthtechBaltimore, US

Ryan Sysko(Executive Officer, Director)inSuzanne Clough(Executive Officer)inKevin McRaith(President and CEO)inAnand Iyer(Chief AI Officer)inChris Bergstrom(Executive Officer)in

BoardTerry Lierman(Director)

Co-investorsMerck Global Health Innovation FundSamsung VenturesAsset Management CompanyDigiTx Partners LLCExcel Venture ManagementMSD Global Health Innovation Fund+2 more

Willowonewillow.com

Willow makes breast pumps and pumping accessories for nursing mothers, including in-bra wearable pumps and collection cups that convert traditional electric pumps into hands-free devices.

ConsumerDirect to ConsumerFemTechHardware

Co-investorsAlumni VenturesGaingelsNew Enterprise Associates (NEA)PortfoliaBoxGroupBurst Capital+3 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

BlueprintClarVistaDOTSDOTS Technology CorpWillow Pump

Exits · 7

4 IPOs · 3 acquisitions · showing 5

AlconNYSE: ALCAlto NeuroscienceNYSE: ANROCVRxNASDAQ: CVRXNovoCureNASDAQ: NVCRMC10acq. by Medidata

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Windham Capital Partners made?
Windham Capital Partners has 46 tracked investments, 7 of which have exited, including 1 dated in the last 24 months.
What stage does Windham Capital Partners invest at?
Windham Capital Partners invests at the Series A, Series B, Series C, Growth stages.
What is Windham Capital Partners's typical check size?
Windham Capital Partners typically writes checks of $1M – $5M.
What sectors does Windham Capital Partners focus on?
Windham Capital Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is Windham Capital Partners located?
Windham Capital Partners is headquartered in New York, US.
Does Windham Capital Partners lead rounds?
Yes, Windham Capital Partners leads investment rounds.
Who does Windham Capital Partners co-invest with?
Windham Capital Partners most often shares deals with New Enterprise Associates (NEA), Gaingels, Alumni Ventures, among 101 tracked co-investors.

Images

Windham Capital Partners photo

Similar investors

Featured in lists